These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3020493)

  • 1. Clinical overview of varicella vaccine: development and early studies.
    Takahashi M
    Pediatrics; 1986 Oct; 78(4 Pt 2):736-41. PubMed ID: 3020493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of live varicella vaccine].
    Takahashi M; Asano Y; Kamiya H; Baba K
    Nihon Rinsho; 1985 Jul; 43(7):1535-41. PubMed ID: 2997506
    [No Abstract]   [Full Text] [Related]  

  • 4. Varicella vaccine studies in healthy children and adults.
    Arbeter AM; Starr SE; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):748-56. PubMed ID: 3020494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox.
    Brunell PA; Taylor-Wiedeman J; Geiser CF; Frierson L; Lydick E
    Pediatrics; 1986 Jan; 77(1):53-6. PubMed ID: 3455669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M; Boudailliez B
    Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of varicella vaccine.
    Plotkin SA; Arbetter AA; Starr SE
    Postgrad Med J; 1985; 61 Suppl 4():155-62. PubMed ID: 3014474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response induced by live attenuated varicella vaccine and short term follow-up on immunity of the vaccinated children.
    Chiba Y; Miura J; Kumagai T; Nakao T
    Biken J; 1984 Sep; 27(2-3):67-71. PubMed ID: 6100061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a live varicella vaccine to hospitalized children and its follow-up study.
    Katsushima N; Yazaki N; Sakamoto M; Fujiyama J; Nakagawa M; Okuyama Y; Takahashi M
    Biken J; 1982 Mar; 25(1):29-42. PubMed ID: 6289798
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live varicella vaccine: prevention of nosocomial infection and protection of high risk infants from varicella infection.
    Sugino H; Tsukino R; Miyashiro E; Dezawa T; Shinohara K; Uemura S; Koike M
    Biken J; 1984 Sep; 27(2-3):63-5. PubMed ID: 6100060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization of acute leukemic children with a live varicella vaccine (Oka strain).
    Kamiya H; Kato T; Isaji M; Torigoe S; Oitani K; Ito M; Ihara T; Sakurai M; Takahashi M
    Biken J; 1984 Sep; 27(2-3):99-102. PubMed ID: 6100066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.
    Brunell PA; Geiser CF; Novelli V; Lipton S; Narkewicz S
    Pediatrics; 1987 Jun; 79(6):922-7. PubMed ID: 3035478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infection.
    Asano Y; Yazaki T; Miyata T; Nakayama H; Hirose S
    Biken J; 1975 Mar; 18(1):35-40. PubMed ID: 167708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active immunization of children exposed to varicella infection in hospitals, using subcutaneous and intradermal attenuated live vaccine].
    Boda D; Bartyik K; Szüts P; Turi S
    Orv Hetil; 1985 Oct; 126(42):2577-80. PubMed ID: 2997687
    [No Abstract]   [Full Text] [Related]  

  • 18. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vaccine against varicella-zoster].
    Nicodemo AC; Nicodemo EL; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(2):55-8. PubMed ID: 2831610
    [No Abstract]   [Full Text] [Related]  

  • 20. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
    Levin MJ; DeBiasi RL; Bostik V; Schmid DS
    J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.